Vertex Pharmaceuticals Incorporated
DE ˙ XTRA ˙ US92532F1003
368,15 € ↑3,40 (0,93%)
2026-06-04
AKTIENPREIS
SecurityDE:VX1 / Vertex Pharmaceuticals Incorporated
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership30,823 shares
Latest Disclosed Value $ 13,763,702
Millennium Management Llc ownership in VX1 / Vertex Pharmaceuticals Incorporated

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 30,823 shares of Vertex Pharmaceuticals Incorporated (DE:VX1) valued at $11,869,937 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 365,664 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -91.57% during the quarter. The current value of the position is $11,347,487 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (VX1) in the form of stock options. The firm currently holds call options representing 54,600 of underlying shares valued at $24,381,084 USD and put options representing 96,900 of underlying shares valued at $43,269,726 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VX1 / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,823 -334,841 -91.57 13,764 -91.70 0.0057
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 365,664 324,622 790.95 165,777 931.40 0.0697
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 41,042 41,042 16,074 0.0069
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -309,935 -100.00 0 -100.00
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 309,935 -708 -0.23 150,263 20.12 0.0800
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 310,643 151,349 95.01 125,096 68.86 0.0611
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 159,294 16,535 11.58 74,084 10.72 0.0351
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 142,759 -182,057 -56.05 66,914 -50.72 0.0310
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 324,816 -317,934 -49.46 135,776 -48.08 0.0580
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 642,750 97,421 17.86 261,529 37.91 0.1132
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 545,329 -521,389 -48.88 189,633 -49.48 0.0957
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,066,718 1,059,682 15,060.86 375,389 16,832.25 0.1851
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,036 -329,526 -97.91 2,217 -97.72 0.0013
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 336,562 333,024 9,412.78 97,192 9,391.41 0.0538
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,538 -287,965 -98.79 1,024 -98.75 0.0006
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 291,503 -21,633 -6.91 82,143 0.52 0.0510
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 313,136 -133,717 -29.92 81,719 -16.72 0.0433
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 446,853 -248,855 -35.77 98,129 -22.24 0.0499
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 695,708 331,296 90.91 126,194 71.75 0.0757
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 364,412 -541,509 -59.77 73,476 -62.26 0.0451
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 905,921 592,174 188.74 194,673 162.54 0.1393
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 313,747 269,398 607.45 74,151 514.44 0.0535
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 44,349 -106,592 -70.62 12,068 -72.46 0.0149
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 150,941 57,693 61.87 43,820 97.49 0.0600
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 93,248 -304,556 -76.56 22,188 -74.53 0.0499
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 397,804 -3,685 -0.92 87,099 28.05 0.1090
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 401,489 -99,114 -19.80 68,020 -25.90 0.1075
2019-08-15 2019-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 500,603 -109,608 -17.96 91,801 -18.22 0.1380
2019-08-14 2019-06-30 13F DELPHI TECHNOLOGIES SHS 92532F100 1,305,733 695,522 26,115
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 610,211 -620,640 -50.42 112,248 -44.97 0.1680
2019-02-15 2018-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,230,851 222,524 22.07 203,964 4.95 0.3180
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,230,851 203,964
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,008,327 344,730 51.95 194,345 72.31 0.2382
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 663,597 95,048 16.72 112,785 21.72 0.1471
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 568,549 -659,534 -53.70 92,662 -49.65 0.1236
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,228,083 -440,125 -26.38 184,041 -27.44 0.2540
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,668,208 890,742 114.57 253,634 153.15 0.3864
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 777,466 -229,594 -22.80 100,192 -9.02 0.1787
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,007,060 461,460 84.58 110,122 173.98 0.2018
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 545,600 246,864 82.64 40,194 54.28 0.0842
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 298,736 296,133 11,376.60 26,053 11,530.80 0.0437
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,603 -677,053 -99.62 224 -99.59 0.0005
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 679,656 -720,481 -51.46 54,026 -69.33 0.1350
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,400,137 -179,237 -11.35 176,179 7.12 0.3704
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,579,374 1,167,738 283.68 164,476 223.59 0.3185
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 411,636 322,607 362.36 50,829 383.95 0.0961
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 89,029 -666,095 -88.21 10,503 -88.29 0.0195
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 755,124 282,174 59.66 89,709 68.89 0.1901
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 472,950 -18,272 -3.72 53,117 14.21 0.1344
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 491,222 257,408 110.09 46,509 181.28 0.1288
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 233,814 123,763 112.46 16,535 102.21 0.0479
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 110,051 -211,203 -65.74 8,177 -66.43 0.0258
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 321,254 61,313 23.59 24,357 17.04 0.0784
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 259,941 259,941 20,811 0.0638
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 54,600 -13.06 24,381 -14.37 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 62,800 -51.91 28,471 -44.34 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 130,600 23.56 51,148 8.69 n/a n/a n/a
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM Call 105,700 -17.68 47,058 -24.41 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Call 128,400 237.01 62,251 305.75 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 38,100 200.00 15,343 159.77 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 12,700 -91.92 5,907 -91.98 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 157,100 16.98 73,636 31.17 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 134,300 -11.70 56,139 -9.29 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 152,100 -14.98 61,888 -0.52 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 178,900 37.09 62,211 35.46 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 130,500 -7.71 45,924 3.08 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 141,400 100.28 44,551 118.52 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 70,600 730.59 20,388 728.44 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 8,500 -80.41 2,461 -79.88 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Call 43,400 12,230 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Call 45,200 -70.88 8,199 -73.80 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 155,200 -8.17 31,293 -13.83 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 169,000 53.64 36,316 39.69 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 110,000 -1.08 25,997 -14.09 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 111,200 30.82 30,260 22.63 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Call 85,000 70.00 24,676 107.40 n/a n/a n/a
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 50,000 -50.00 11,898 -45.66 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 100,000 21,895 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 100,000 -39.39 18,338 -39.58 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 100,000 18,338 n/a n/a n/a
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 165,000 65.00 30,352 83.16 n/a n/a n/a
2019-02-15 2018-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 100,000 -0.99 16,571 -14.88 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Call 100,000 16,571 n/a n/a n/a
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM Call 101,000 -32.67 19,467 -23.64 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM Call 150,000 95.06 25,494 103.41 n/a n/a n/a
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 76,900 1,438.00 12,533 1,573.30 n/a n/a n/a
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM Call 5,000 -85.71 749 -85.92 n/a n/a n/a
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM Call 35,000 -73.08 5,321 -68.24 n/a n/a n/a
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM Call 130,000 23.81 16,753 45.91 n/a n/a n/a
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM Call 105,000 110.00 11,482 211.67 n/a n/a n/a
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM Call 50,000 25.00 3,684 5.62 n/a n/a n/a
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM Call 40,000 -20.00 3,488 -18.90 n/a n/a n/a
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM Call 50,000 4,301 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM Call 50,000 -87.31 5,616 -84.94 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM Call 393,900 410.23 37,294 583.04 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM Call 77,200 91.56 5,460 69.25 n/a n/a n/a
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM Call 40,300 3,226 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 96,900 62.86 43,270 60.41 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 59,500 18.76 26,975 37.48 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 50,100 25.56 19,621 10.46 n/a n/a n/a
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 39,900 -50.06 17,763 -54.14 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 79,900 46.61 38,737 76.50 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 54,500 434.31 21,947 362.72 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 10,200 -82.83 4,744 -82.96 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 59,400 53.49 27,842 72.11 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 38,700 -63.42 16,177 -62.42 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 105,800 -13.14 43,049 1.64 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 121,800 81.25 42,355 79.10 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 67,200 -50.70 23,648 -44.93 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 136,300 61.88 42,944 76.62 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 84,200 54.50 24,315 54.09 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 54,500 -58.04 15,780 -56.89 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Put 129,900 19.28 36,605 28.80 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 108,900 71.77 28,420 104.12 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 63,400 -31.01 13,923 -16.48 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Put 91,900 -15.14 16,670 -23.66 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 108,300 -56.35 21,837 -59.04 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Put 248,100 594.96 53,314 531.91 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Put 35,700 6.57 8,437 -7.45 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 33,500 22.26 9,116 14.61 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Put 27,400 -40.82 7,954 -27.80 n/a n/a n/a
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 46,300 11,017 n/a n/a n/a
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM Put 205,000 22,417 n/a n/a n/a
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM Put 75,000 -67.39 6,452 -64.71 n/a n/a n/a
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM Put 230,000 53.33 18,283 -3.14 n/a n/a n/a
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM Put 150,000 0.00 18,875 20.83 n/a n/a n/a
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM Put 150,000 15,621 n/a n/a n/a
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Put 100,000 -66.67 11,880 -64.74 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM Put 300,000 -44.19 33,693 -33.79 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM Put 537,500 -14.21 50,891 14.86 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM Put 626,500 253.56 44,306 236.52 n/a n/a n/a
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS COM Put 177,200 46.45 13,166 43.51 n/a n/a n/a
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM Put 121,000 9,174 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.